Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Seeen CEO raises stake

(Sharecast News) - Seeen revealed on Monday that chief executive officer Adrian Hargrave had acquired 80,645 ordinary shares in the AIM-listed media and technology platform group. Hargrave, who took over as CEO in July 2022, purchased the shares on Friday at an average price of 3.10p each, for a total value of £2,499.99.

Following the transaction, Hargrave holds a beneficial interest in a total of 2.06m ordinary Seeen shares, representing approximately 1.72% of the company's issued share capital.

As of 1550 BST, Seeen shares were down 4.76% at 3.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Seen (SEEN) Director name: Hargrave,Adrian Amount purchased: 80,645 @ 3.10p Value: £2,499.99

Top Director Sells

Share this article

Related Sharecast Articles

Director dealings: Jadestone CEO snaps up shares
(Sharecast News) - Jadestone Energy revealed on Wednesday that chief executive Alexander Blakeley had acquired 443,100 ordinary shares in the AIM-listed upstream production company.
Director dealings: Travis Perkins CEO snaps up shares
(Sharecast News) - Travis Perkins revealed on Tuesday that chief executive Pete Redfern had acquired 249,218 ordinary shares in the FTSE 250-listed builders' merchant.
Director dealings: Arcontech CEO invests, Hargreaves Services director conducts sale-and-repurchase
(Sharecast News) - Matthew Jeffs, chief executive officer of Arcontech Group, disclosed a series of personal share purchases in the company on Monday, amounting to a total of 60,000 ordinary shares.
Director dealings: Haleon's Alan Stewart snaps up shares
(Sharecast News) - Haleon revealed on Friday that non-executive director Alan Stewart had acquired 33,923 ordinary shares in the London-listed consumer healthcare business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.